Can-Fite BioPharma (CANF) Reports FY23 Results, Issues Clinical Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a report published on Thursday morning. The firm issued a hold rating on the stock. Can-Fite BioPharma Stock Up 1.8 % Shares of CANF opened at $2.23 on Thursday. Can-Fite BioPharma has a 52 week low of $1.52 and a 52 week […]
Form 6-K Can-Fite BioPharma Ltd. For: Mar 11 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncology and inflammatory diseases, today announced its VP of Business.
StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE:CANF) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.